6.
Shen J, Ma B, Zhang X, Sun X, Han J, Wang Y
. Thioridazine has potent antitumor effects on lung cancer stem-like cells. Oncol Lett. 2017; 13(3):1563-1568.
PMC: 5403693.
DOI: 10.3892/ol.2017.5651.
View
7.
Xia Y, Sun M, Huang H, Jin W
. Drug repurposing for cancer therapy. Signal Transduct Target Ther. 2024; 9(1):92.
PMC: 11026526.
DOI: 10.1038/s41392-024-01808-1.
View
8.
Papadopoulos F, Isihou R, Alexiou G, Tsalios T, Vartholomatos E, Markopoulos G
. Haloperidol Induced Cell Cycle Arrest and Apoptosis in Glioblastoma Cells. Biomedicines. 2020; 8(12).
PMC: 7763579.
DOI: 10.3390/biomedicines8120595.
View
9.
Matteoni S, Matarrese P, Ascione B, Buccarelli M, Ricci-Vitiani L, Pallini R
. Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation . Front Oncol. 2021; 11:635472.
PMC: 7952964.
DOI: 10.3389/fonc.2021.635472.
View
10.
Tegowski M, Fan C, Baldwin A
. Thioridazine inhibits self-renewal in breast cancer cells via DRD2-dependent STAT3 inhibition, but induces a G arrest independent of DRD2. J Biol Chem. 2018; 293(41):15977-15990.
PMC: 6187640.
DOI: 10.1074/jbc.RA118.003719.
View
11.
Yong M, Yu T, Tian S, Liu S, Xu J, Hu J
. DR2 blocker thioridazine: A promising drug for ovarian cancer therapy. Oncol Lett. 2018; 14(6):8171-8177.
PMC: 5755240.
DOI: 10.3892/ol.2017.7184.
View
12.
Sandhya L, Devi Sreenivasan N, Goenka L, Dubashi B, Kayal S, Solaiappan M
. Randomized Double-Blind Placebo-Controlled Study of Olanzapine for Chemotherapy-Related Anorexia in Patients With Locally Advanced or Metastatic Gastric, Hepatopancreaticobiliary, and Lung Cancer. J Clin Oncol. 2023; 41(14):2617-2627.
DOI: 10.1200/JCO.22.01997.
View
13.
Cheng H, Liang Y, Kuo Y, Chuu C, Lin C, Lee M
. Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data. Cell Death Dis. 2015; 6:e1753.
PMC: 4669717.
DOI: 10.1038/cddis.2015.77.
View
14.
Angelini A, Ciofani G, Conti P
. ANTIPSYCHOTICS REVERSE P-GLYCOPROTEIN-MEDIATED DOXORUBICIN RESISTANCE IN HUMAN UTERINE SARCOMA MES-SA/Dx5 CELLS: A NOVEL APPROACH TO CANCER CHEMOTHERAPY. J Biol Regul Homeost Agents. 2015; 29(2):357-65.
View
15.
Martins A, Ordonez J, Amaral A, Prins F, Floris G, Debiec-Rychter M
. IGF1R signaling in Ewing sarcoma is shaped by clathrin-/caveolin-dependent endocytosis. PLoS One. 2011; 6(5):e19846.
PMC: 3096649.
DOI: 10.1371/journal.pone.0019846.
View
16.
Tuan N, Lee C
. Penfluridol as a Candidate of Drug Repurposing for Anticancer Agent. Molecules. 2019; 24(20).
PMC: 6832311.
DOI: 10.3390/molecules24203659.
View
17.
Townsend M, Pareja K, Buchanan-Hughes A, Worthington E, Pritchett D, Brubaker M
. Antipsychotic-Related Stigma and the Impact on Treatment Choices: A Systematic Review and Framework Synthesis. Patient Prefer Adherence. 2022; 16:373-401.
PMC: 8859276.
DOI: 10.2147/PPA.S343211.
View
18.
Hoertel N, Sanchez-Rico M, Vernet R, Jannot A, Neuraz A, Blanco C
. Observational study of haloperidol in hospitalized patients with COVID-19. PLoS One. 2021; 16(2):e0247122.
PMC: 7895415.
DOI: 10.1371/journal.pone.0247122.
View
19.
Wang Y, Huang N, Li H, Liu S, Chen X, Yu S
. Promoting oligodendroglial-oriented differentiation of glioma stem cell: a repurposing of quetiapine for the treatment of malignant glioma. Oncotarget. 2017; 8(23):37511-37524.
PMC: 5514926.
DOI: 10.18632/oncotarget.16400.
View
20.
Wang J, Zhu H, Markowitz J, Donovan J, Yuan H, Devane C
. Antipsychotic drugs inhibit the function of breast cancer resistance protein. Basic Clin Pharmacol Toxicol. 2008; 103(4):336-41.
PMC: 2637613.
DOI: 10.1111/j.1742-7843.2008.00298.x.
View